Sifting through countless of stocks in the Health Care Technology industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Schrödinger, Inc. or Docebo Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.
Read on to learn how Schrödinger, Inc. and Docebo Inc. compare based on key financial metrics to determine which better meets your investment needs.
About Schrödinger, Inc. and Docebo Inc.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Docebo Inc. develops and provides learning management platform for training in Canada, the United States, and internationally. The company’s cloud platform consists of a learning suite, which includes Docebo Learn platform, a cloud-based learning platform that allows learning administrators to deliver personalized learning; Docebo Content Marketplace, an access to off-the-shelf learning content and provide predeveloped learning content; Insights module allows organizations to understand the results of learning programs with data visualizations; Learning Evaluation module to incorporate the learner’s perspective into analyses by collection of feedback; and Advanced Analytics Pack to integrate learning data into data ecosystem and BI tool. It also offers Communities module enabling interactive learner communities; eCommerce module that monetize from digital training contents, as well as manage and sells training offerings; eCommerce module to monetize training programs; Docebo Integrations; Headless Learning allows businesses to build learning experiences outside of the Docebo learning environment; Harmony Search, an AI-powered search capability. In addition, the company provides Docebo Creator enables organizations to design, scale, and deploy learning contents; Docebo for Salesforce, an integration of Salesforce’s APIs and technology architecture to deliver a learning experience within Salesforce workflows; Docebo Embed (OEM) enables original equipment manufacturers to embed and resell the Docebo learning platform; Docebo Branded Mobile App Publisher, allows organizations to create and distribute a branded version of Docebo’s mobile learning application; Docebo Extended Enterprise supports customer education, partner enablement, and retention by enabling organizations to train external audiences from a single LMS; and Docebo for Microsoft Teams. The company was founded in 2005 and is headquartered in Toronto, Canada.
Latest Health Care Technology and Schrödinger, Inc., Docebo Inc. Stock News
As of July 31, 2026, Schrödinger, Inc. had a $1.1 billion market capitalization, compared to the Health Care Technology median of $179.6 million. Schrödinger, Inc.’s stock is down 15.3% in 2026, up 1.1% in the previous five trading days and down 26.85% in the past year.
Currently, Schrödinger, Inc. does not have a price-earnings ratio. Schrödinger, Inc.’s trailing 12-month revenue is $254.9 million with a -40.6% net profit margin. Year-over-year quarterly sales growth most recently was -1.7%. Analysts expect adjusted earnings to reach $-2.250 per share for the current fiscal year. Schrödinger, Inc. does not currently pay a dividend.
As of July 31, 2026, Docebo Inc. had a $514.3 million market cap, putting it in the 38th percentile of all stocks. Docebo Inc.’s stock is down 6.9% in 2026, up 6.7% in the previous five trading days and down 32.07% in the past year.
Currently, Docebo Inc.’s price-earnings ratio is 17.4. Docebo Inc.’s trailing 12-month revenue is $251.0 million with a 13.7% net profit margin. Year-over-year quarterly sales growth most recently was 14.5%. Analysts expect adjusted earnings to reach $1.609 per share for the current fiscal year. Docebo Inc. does not currently pay a dividend.
How We Compare Schrödinger, Inc. and Docebo Inc. Stock Grades
Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.
AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Schrödinger, Inc. and Docebo Inc.’s stock grades to see how they measure up against one another.
Learn more about A+ Investor here!
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
Schrödinger, Inc. and Docebo Inc. Stock Value Grades
| Company | Ticker | Value |
| Schrödinger, Inc. | SDGR | F |
| Docebo Inc. | DCBO | C |
Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.
Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.
AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.
Schrödinger, Inc. has a Value Score of 20, which is Ultra Expensive.
Docebo Inc. has a Value Score of 58, which is Average.
The Value Stock Winner: No Clear Winner
Neither Schrödinger, Inc. or Docebo Inc. has a high enough value grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolio. It’s important to look at a wide range of financial metrics in order to determine if Schrödinger, Inc. or Docebo Inc. is the better investment when it comes to value.
Schrödinger, Inc. and Docebo Inc.’s Quality Grades
| Company | Ticker | Quality |
| Schrödinger, Inc. | SDGR | D |
| Docebo Inc. | DCBO | C |
Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.
The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.
The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.
Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.
Schrödinger, Inc. has a Quality Score of 31, which is Weak.
Docebo Inc. has a Quality Score of 55, which is Average.
The Quality Stock Winner: No Clear Winner
Neither Schrödinger, Inc. or Docebo Inc. has a high enough Quality Grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Schrödinger, Inc. or Docebo Inc. is the better investment when it comes to quality.
Schrödinger, Inc. and Docebo Inc.’s Momentum Grades
| Company | Ticker | Momentum |
| Schrödinger, Inc. | SDGR | C |
| Docebo Inc. | DCBO | D |
Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.
Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.
Schrödinger, Inc. has a Momentum Score of 41, which is Average.
Docebo Inc. has a Momentum Score of 23, which is Weak.
The Momentum Stock Winner: No Clear Winner
Neither Schrödinger, Inc. or Docebo Inc. has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Schrödinger, Inc. or Docebo Inc. is the better investment when it comes to momentum.
Don’t Forget Your Free Special Report on How A+ Grades Can Help You Make Investment Decisions
Other Schrödinger, Inc. and Docebo Inc. Grades
In addition to Value, Quality and Momentum, A+ Investor also provides grades for Growth and Estimate Revisions.
Earnings estimate revisions scores take into account the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, surprises beget further surprises‐or at least continued sales growth (the exact opposite is generally true, too).
Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.
These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Schrödinger, Inc. and Docebo Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.
So, Which Is the Better Investment, Schrödinger, Inc. or Docebo Inc. Stock?
Overall, Schrödinger, Inc. stock has a Value Score of 20, Momentum Score of 41 and Quality Score of 31.
Docebo Inc. stock has a Value Score of 58, Momentum Score of 23 and Quality Score of 55.
Comparing Schrödinger, Inc. and Docebo Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.
Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.
A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.
AAII Disclaimer
We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.
Included With AAII Platinum
Screen: 23.7%
Annual Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.